Skip to content
PICO Portalanswers from OpenAlex

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib

PaperCitations, authors & open-access status

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib is a paper indexed in PICO Portal from OpenAlex.

How many citations does Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib have?

PICO Portalcitation count

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib has 96 citations in the OpenAlex counts PICO Portal stores.

When was Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib published?

PICO Portalyear

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib has 2013 year in the PICO Portal index.

What is the open-access status of Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib?

PICO Portaloa status

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib has hybrid oa status in the PICO Portal index.

What is the DOI of Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib?

PICO Portaldoi

The DOI for Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib is on the source record.

What is the PMID of Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib?

PICO Portalpmid

The PMID for Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib is on the source record.

What is the OpenAlex record for Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib?

PICO Portalopenalex

The OpenAlex for Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial